Please assess the completion status of the following clinical trial:

Trial Title: An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Completed the treatment period of Study ALK9072-003EXT~* Continues to require chronic treatment with an antipsychotic medication~* Continues to reside in a stable living situation~* Continues to have an identified reliable informant~Exclusion Criteria:~* Abnormal clinical laboratory value, vital sign, or electrocardiogram (ECG) finding during participation in Study ALK9072-003EXT that was clinically relevant and related to study drug~* Missed more than 1 scheduled study visit during participation in the preceding Study ALK9072-003EXT~* Has a significant or unstable medical condition that would preclude safe completion of the current study~* Subject is pregnant or breastfeeding~* Subject expects to be incarcerated, or has pending legal action which may impact compliance with study participation or procedures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- ALKS 9072, Low Dose (Type: EXPERIMENTAL): None
- ALKS 9072, High Dose (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).